Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
1(10%)
Results Posted
63%(5 trials)

Phase Distribution

Ph phase_4
4
40%
Ph phase_2
1
10%
Ph phase_3
3
30%
Ph phase_1
1
10%
Ph not_applicable
1
10%

Phase Distribution

1

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
4(40.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(8)

Detailed Status

Completed8
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 21 (10.0%)
Phase 33 (30.0%)
Phase 44 (40.0%)
N/A1 (10.0%)

Trials by Status

completed880%
enrolling_by_invitation110%
recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
completedphase_4

Exparel Versus Bupivacaine in Post-operative Pain Control

NCT06547255
enrolling_by_invitationphase_2

Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain

NCT06077422
recruitingnot_applicable

Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine

NCT06471348
completedphase_4

ESP Block for Post Cesarean Analgesia

NCT05664958
completedphase_3

Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty

NCT05139030
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06547255Phase 4

Exparel Versus Bupivacaine in Post-operative Pain Control

Completed
NCT06077422Phase 2

Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain

Enrolling By Invitation
NCT06471348Not Applicable

Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine

Recruiting
NCT05664958Phase 4

ESP Block for Post Cesarean Analgesia

Completed
NCT05139030Phase 3

Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty

Completed
NCT02713230Phase 3

Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery

Completed
NCT02713178Phase 3

Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty

Completed
NCT04158102Phase 1

Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects

Completed
NCT04102267Phase 4

Extended Delivery of Bupivacaine Study in Herniorrhaphy

Completed
NCT02682498Phase 4

Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10